Skip to main content

Find a Clinical Trial

Filter

Services
Showing 1 - 10 out of 11
Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin (VOLGA)
medical-cross
Bladder cancer
user
All genders
person-wave 18+
world
Recruiting now
info
Department of Medicine, Cancer Center
Learn more
PFO-PAS
medical-cross
Stroke
user
All genders
person-wave 18-60
world
Recruiting now
info
Department of Neurology
Learn more
ASPIRE
medical-cross
Intracerebral hemorrhage
user
All genders
person-wave 18+
world
Recruiting now
info
Department of Neurology
Learn more
ARCADIA
medical-cross
Stroke
user
All genders
person-wave 45+
world
Recruiting now
info
Department of Neurology
Learn more
Feasibility of a new method for non-invasive monitoring of low-grade bladder cancer
medical-cross
Bladder cancer
user
All genders
person-wave 18-90
world
Recruiting now
info
Department of Urology
Learn more
Sleep SMART
medical-cross
Stroke
user
All genders
person-wave 18+
world
Recruiting now
info
Department of Neurology
Learn more
Jump back to top